Similar Articles
481 Liver resection vs radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients
482 Deep learning in hepatocellular carcinoma: Current status and future perspectives
483 New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study
484 Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report
485 Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma
486 Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
487 Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
488 Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
489 Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
490 Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA